Ginobolt-MP2 Tablets

Ginobolt-MP2 is a triple combination anti-diabetic therapy for effective control of Type 2 Diabetes Mellitus, especially in patients not responding adequately to dual therapy.

• Metformin SR – Improves insulin sensitivity and reduces glucose production in the liver.

• Glimepiride – Stimulates insulin release from pancreatic beta cells.

• Pioglitazone – Enhances peripheral glucose uptake and utilisation.

This combination offers comprehensive blood sugar management while minimising fluctuations.

Benefits:

• Triple Mechanism of Action – Targets insulin resistance, deficiency, and excess glucose production.

• Improved Glycaemic Control – Suitable for patients with persistent high sugar levels.

• Long-Lasting Effect – SR formulation for better patient compliance.

• Reduces Risk of Complications – Supports cardiovascular and metabolic health.

Dosage:

One tablet daily with meals, or as directed by a healthcare professional.

Why Cardiever?

• Expert in Cardio-Diabetic Care – Specialised, research-backed formulations.

• GMP & ISO Quality Standards – Ensuring safety, efficacy, and consistency.

• Affordable for Long-Term Therapy – Cost-effective treatment without compromising quality.

• Doctor-Trusted Brand – Widely recommended for chronic diabetes management.